Table 2 Costs over 32 weeks (intention-to-treat)
ESM-I (n = 33) | Pseudo-intervention (n = 35) | Control (n = 33) | Regression coefficients; B (p-value obtained from permutation analyses) | ||
|---|---|---|---|---|---|
M (SD) | M (SD) | M (SD) | ESM-I vs Control | ESM-I vs Pseudo-intervention | |
Health care use (total)a | €6751 (€19420) | €6510 (€7315) | €6520 (€14082) | -€165 (p = 0.96) | €1818 (p = 0.66) |
Medication | €104 (€296) | €25 (€56) | €75 (€171) | €12 (p = 0.82) | €36 (p = 0.54) |
Total health costsb | €7648 (€19402) | €7225 (€7304) | €6596 (€14072) | €640 (p = 0.80) | €1957 (p = 0.61) |
Societal | |||||
Absence from work | €6067 (€13691) | €4732 (€9372) | €5379 (€11889) | €945 (p = 0.74) | €857 (p = 0.75) |
Productivity loss at work | €4234 (€7721) | €4858 (€8438) | €4241 (€7627) | €605 (p = 0.76) | -€594 (p = 0.80) |
Total | €17957 (€31329) | €16816 (€17595) | €16216 (€27756) | €2483 (p = 0.74) | €2152 (p = 0.75) |